MedPath

济南高华制药有限公司

Ownership
-
Established
1994-12-22
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

8

NMPA:8

Drug Approvals

Mecobalamin Tablets

Product Name
甲钴胺片
Approval Number
国药准字H20249835
Approval Date
Dec 25, 2024
NMPA

Hydrotalcite Chewable Tablets

Product Name
铝碳酸镁咀嚼片
Approval Number
国药准字H20244989
Approval Date
Sep 26, 2024
NMPA

Fumnrat clemastine

Product Name
富马酸氯马斯汀
Approval Number
国药准字H37020016
Approval Date
Apr 13, 2020
NMPA

Enoxacin Tablets

Product Name
依诺沙星片
Approval Number
国药准字H20033418
Approval Date
Apr 13, 2020
NMPA

Indapamide Tablets

Product Name
吲达帕胺片
Approval Number
国药准字H10983096
Approval Date
Apr 13, 2020
NMPA

Indapamide Sustained-release Tablets

Product Name
平至
Approval Number
国药准字H20052258
Approval Date
Apr 13, 2020
NMPA

Clemastine Fumarate Tablets

Product Name
富马酸氯马斯汀片
Approval Number
国药准字H37020017
Approval Date
Apr 13, 2020
NMPA

Indapamide

Product Name
吲达帕胺
Approval Number
国药准字H19983025
Approval Date
Apr 13, 2020
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.